2014 Rules Revisions, Wyoming Pharmacy Act
Governor Matthew Mead signed two sets of rules revisions
in 2014. The Wyoming State Board of Pharmacy members and
staff reviewed all 17 chapters of rules and regulations under the
Wyoming Pharmacy Act and all eight chapters under the Wyoming
Controlled Substances Act. Spelling, grammar, numbering, and formatting
were corrected throughout, and many other revisions were
suggested and debated. A public comment period of 45 days was
announced and a public hearing was held on November 5, 2013, in
Casper, WY. Many comments were received. Three chapters were
tabled until February 2014, and then the rulemaking notice went
forward. A summary of revisions to the rules under the Wyoming
Pharmacy Act are as follows:
Chapter 1, Board Practice, has updated procedures for complaints,
investigations, and hearings.
Chapter 2, General Practice, has updated definitions, including
for medication therapy management, which now includes Clinical
Laboratory Improvement Amendments-waived testing. Wyoming
will accept reciprocity from pharmacists licensed in California after
January 1, 2004. Access to the Board’s website will suffice rather
than binders for Newsletters or the “Orange Book.” Three feet is
the minimum separation between patients at a pharmacy window.
Notifications are now required for changes in ownership (21 days),
changes in pharmacist-in-charge (PIC) (seven days), changes in a
pharmacy address (30 days), and change in employment or address
(15 days). A PIC can be absent from a pharmacy for up to 30 days
for illness, vacation, etc, without requiring a change in PIC. Shipments
are to be checked for contamination or counterfeiting, and
items are to be quarantined for recalls. If a pharmacist is not on
site at a retail pharmacy, a sign is to be posted. Interns may transfer
non-controlled substance prescriptions out and in if a pharmacist
is on the other end of the transaction. A pharmacy technician (but
not a technician-in-training) may transfer non-controlled prescriptions
out to a pharmacist. The prescription label shall include the
purpose for use, where appropriate. Changes to the requirements
for emergency drug boxes in long-term care are listed in Section
25. Under collaborative practice, a pharmacist can now make
agreements with practitioners other than physicians.
Chapter 3 clarifies definitions and intern hour requirements.
Chapter 4 updates the Code of Ethics. Chapter 5, Poisons, was
repealed in 2011. The chapter 6 title was changed to Continuing
Professional Education and clarifies auditing of earned hours using
the National Association of Boards of Pharmacy® CPE Monitor®
program.
Chapter 7, Computers, was repealed in 2011. Chapter 8, Manufacturers
and Distributors, was reviewed but not revised. Chapter
9, Counseling and DUR, has updated language, and duplicate
requirements were eliminated.
Chapter 10, Technicians, was a hot topic, and the final version
was tabled until February 2014. The sections have been rearranged
and the “grace period” for license renewal has been changed to
10 days following notification. The ratio of pharmacy technicians
and/or technicians-in-training to pharmacists remains at 3:1, not
counting enrollees in an American Society of Health-System
Pharmacists-accredited training program during required experiential
training hours.
Chapter 11, Dangerous Drugs, was repealed. Chapter 12, Institutional
Practice, has several revisions, including how to destroy
used transdermal controlled substance (CS) patches. Chapter 13
has a new title, Non-Sterile Compounding, and adds a Master
Compounding Record requirement. Chapter 14, Telepharmacy,
was not revised. Chapter 15, Long Term Care, clarifies the roles
of the provider pharmacy and consultant pharmacist.
Chapter 16, Immunizations, was extensively revised due to
changes in the statute, and articles appeared in previous Newsletters.
Pharmacists can administer influenza vaccine to minors aged
seven to 17 and to adults 18 years and over, as listed. Private space
is described and must be in place by July 20, 2014. All administered
vaccines must be reported to the state registry. Chapter 17, Sterile
Compounding, was not revised.
All current rules and statutes are posted on the Board website
at http://pharmacyboard.state.wy.us.
quoted from here
No comments:
Post a Comment